Biotech Values

[jbog]

I think in general the street has no patience with the bio sector at this point. They're sick of all the delayed and false promises and projections and instead will be happy to wait for the results prior to rewarding the company. The past number of years has thrown a hatchet in everyone's timelines yet they keep on spending and diluting as they move forward.

In revances case just how many 100,s of millions were wasted as they fiddled with the FDA? Then they have the gall to say they'll rollout Daxi maybe 5 or 6 months after approval for CD.

Then RVNC confirms they'll be cash flow positive before they run out of funds, oh and by the way our sales suck and we're cutting the price.

Astonishing.